A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis

Inclusion Criteria: * Documented history of non-infectious anterior, anterior and intermediate- or panuveitis * Currently uncontrolled uveitis for a minimum of 2 weeks despite use of oral and/or topical corticosteroid,or subjects who are intolerant of local corticosteroid therapy due to the development of an ocular hypertensive response or subjects for whom oral corticosteroid is contraindicated. * Grade of 2+ or higher for anterior chamber cells at time of enrollment * Considered by the investigator to require corticosteroid-sparing therapy. * Subjects not planning to undergo elective ocular surgery during the study Exclusion Criteria: * Uveitis of infectious etiology * Presence of an ocular toxoplasmosis scar * An immune suppression regimen that includes an alkylating agent within the previous 90 days